LAB FY 2019 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

FY 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$117M+3.8% YoY

Gross Profit

$64M54.8% margin

Operating Income

-$52M-44.2% margin

Net Income

-$65M-55.3% margin

EPS (Diluted)

$-0.97

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$38M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$265M

Total Liabilities

$111M

Stockholders' Equity

$154M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$117M	$113M	+3.8%
Gross Profit	$64M	$62M	+4.3%
Operating Income	-$52M	-$48M	-7.6%
Net Income	-$65M	-$59M	-9.8%